<DOC>
	<DOCNO>NCT01207739</DOCNO>
	<brief_summary>The purpose study establish whether prolonged antibiotic treatment patient diagnose proven presume PLD ( endorse international ILADS guideline ) lead well patient outcome short-term treatment endorse Dutch CBO guideline .</brief_summary>
	<brief_title>Persistent Lyme Empiric Antibiotic Study Europe</brief_title>
	<detailed_description />
	<mesh_term>Lyme Disease</mesh_term>
	<mesh_term>Borrelia Infections</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Hydroxychloroquine</mesh_term>
	<criteria>Males nonpregnant , nonlactating female 18 year old . Women childbearing potential must agree use contraception method oral contraceptive study therapy period , since failure oral contraceptive due longterm antibiotic use describe doxycycline might teratogenic . Patients presume proven PLD . In study , clinical suspicion PLD define complaint musculoskeletal pain , arthritis arthralgia , neuralgia sensory disturbance ( paresthesias dysesthesias ) , neuropsychological cognitive disorder , persistent fatigue , : temporally related episode erythema migrans otherwise proven symptomatic Lyme disease ( define within 4 month erythema migrans assess physician , positive biopsy , PCR , culture , intrathecal B. burgdorferi antibody ) , OR accompany positive B. burgdorferi IgG IgM immunoblot ( define strict criterion line European Union Concerted Action Lyme Borreliosis ( EUCALB ) ) , regardless prior ELISA IgG/IgM screen result . Subjects must sign write informed consent form . Subjects know history allergy intolerance tetracycline , macrolides , hydroxychloroquine ceftriaxone . Subjects 5 day antimicrobial therapy activity B. burgdorferi within previous 4 week . Subjects presumed diagnosis neuroborreliosis ( CSF pleocytosis intrathecal antibody production ) intravenous antimicrobial therapy require . Subjects know diagnosis HIVseropositivity immune disorder . ( No HIV serologic test require study ) . Subjects positive syphilis serology sign spirochetal disease . Subjects moderate severe liver disease define alkaline phosphatase , ALAT , ASAT great 3 time upper limit normal . Subjects receive discontinue cisapride , astemizole , terfenadine , barbiturate , phenytoin , carbamazepine ( The concentration drug may increase clarithromycin therapy and/or lead reduce availability doxycycline ) . Subjects currently enrol investigational drug trial receive investigational agent . Subjects previously randomize study . Severe physical psychiatric comorbidity interfere participation study protocol , include previous medical diagnosis rheumatic condition , chronic fatigue syndrome chronic pain condition well insufficient command Dutch language . Comorbidity could ( partially ) account symptom subject ( e.g . vitamin B12 deficiency , anemia , hypothyroidism ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Prolonged antibiotic treatment Lyme disease</keyword>
	<keyword>Doxycycline</keyword>
	<keyword>Clarithromycin</keyword>
	<keyword>Hydroxychloroquine</keyword>
</DOC>